NYSE: BHVN - Biohaven Pharmaceutical Holding Company Ltd.

Lønnsomhet i seks måneder: +9.18%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Biohaven Pharmaceutical Holding Company Ltd.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd., биофармацевтическая компания на клинической стадии, разрабатывает продукты-кандидаты на поздних стадиях, нацеленные на неврологические заболевания и редкие расстройства в Соединенных Штатах. Его продукты на клинической стадии включают Римегепант, продукт, который прошел III фазу испытаний для лечения острых состояний и профилактики мигрени; Вазегепант, завершивший испытание фазы 2> F3 по неотложному лечению и профилактике мигрени; и Трорилузол, завершивший фазу рандомизации II \ u002FIII и продолжающийся расширенное исследование атаксии.

flere detaljer
Компания также предлагает Трорилузол, который находится в клинической фазе II> III фазы при обсессивно-компульсивных расстройствах и болезни Альцгеймера; BHV-0223, препарат для лечения бокового амиотрофического склероза; BHV-5000, продукт, прошедший фазу I клинических испытаний нейропсихиатрических расстройств; и Verdiperstat, продукт, который проходит III фазу испытаний для лечения множественной системной атрофии. Biohaven Pharmaceutical Holding Company Ltd. заключила соглашение о сотрудничестве с Cove, чтобы облегчить телемедицинскую оценку для страдающих мигренью. Компания была основана в 2013 году, ее штаб-квартира находится в Нью-Хейвене, штат Коннектикут.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2022-09-23
ISIN VGG111961055
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.biohavenpharma.com
Цена ао 42.12
Prisendring per dag: 0% (42.12)
Prisendring per uke: +8.33% (38.88)
Prisendring per måned: +18.41% (35.57)
Prisendring over 3 måneder: -13.44% (48.66)
Prisendring over seks måneder: +9.18% (38.58)
Prisendring per år: -10.61% (47.12)
Prisendring over 3 år: 0% (42.12)
Prisendring over 5 år: 0% (42.12)
Prisendring over 10 år: 0% (42.12)
Prisendring siden begynnelsen av året: +16.51% (36.15)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 13.12 1
P/BV 7.2 1
P/E 0 0
EV/EBITDA -6.62 0
Total: 3.88

Effektivitet

Navn Betydning Karakter
ROA, % -79.53 0
ROE, % -95.37 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0714 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 622.66 10
Lønnsomhet Ebitda, % -18.69 0
Lønnsomhet EPS, % -47.46 0
Total: 2
Flere detaljer

Transaksjonsdato Avsløringsdato Insider Type Pris Volum Mengde Del opp til, % Del etterpå, % Dokument
05.01.2025 07.01.2025 Coric Vlad
Chief Executive Officer		 Kjøpe 39.51 563 018 14250 0 0.02 link
05.01.2025 07.01.2025 Buten Matthew
Chief Financial Officer		 Kjøpe 39.51 167 918 4250 0 0.01 link
05.01.2025 07.01.2025 Clark George C.
VP, Chief Accounting Officer		 Kjøpe 39.51 98 775 2500 0 0 link
19.08.2022 22.08.2022 Bailey Gregory
Director		 Kjøpe 148.04 5 625 520 38000 0 0.06 link
07.01.2022 07.01.2022 Coric Vlad
Chief Executive Officer		 Kjøpe 129.48 1 294 800 10000 0 0.02 link
07.01.2022 07.01.2022 JONES WILLIAM A JR
CCO-Migraine & Common Disease		 Kjøpe 129.48 485 550 3750 0 0.01 link
07.01.2022 07.01.2022 Stock Elyse
Chief Medical Officer		 Kjøpe 129.48 129 480 1000 0 0 link
07.01.2022 07.01.2022 Stock Elyse
Chief Medical Officer		 Kjøpe 129.48 420 810 3250 0 0 link
07.01.2022 07.01.2022 Engelhart James
Strategic Advisor		 Kjøpe 129.48 420 810 3250 0 0 link
06.01.2022 07.01.2022 Coric Vlad
Chief Executive Officer		 Kjøpe 129.48 1 618 500 12500 0 0.02 link
06.01.2022 07.01.2022 JONES WILLIAM A JR
CCO-Migraine & Common Disease		 Kjøpe 129.48 647 400 5000 0 0.01 link
06.01.2022 07.01.2022 Stock Elyse
Chief Medical Officer		 Kjøpe 129.48 161 850 1250 0 0 link
06.01.2022 07.01.2022 Stock Elyse
Chief Medical Officer		 Kjøpe 129.48 485 550 3750 0 0.01 link
06.01.2022 07.01.2022 Engelhart James
Strategic Advisor		 Kjøpe 129.48 485 550 3750 0 0.01 link
10.12.2021 10.12.2021 Engelhart James
Chief Financial Officer		 Salg 102.55 3 589 250 35000 0 -0.05 link
10.12.2021 10.12.2021 Engelhart James
Chief Financial Officer		 Kjøpe 99.73 3 490 550 35000 0 0.05 link
06.01.2021 08.01.2021 Coric Vlad
Chief Executive Officer		 Kjøpe 85.72 1 071 500 12500 0 0.02 link
06.01.2021 08.01.2021 Conway Charles
Chief Scientific Officer		 Kjøpe 85.72 321 450 3750 0 0.01 link
06.01.2021 08.01.2021 Engelhart James
Chief Financial Officer		 Kjøpe 85.72 321 450 3750 0 0.01 link
25.11.2020 27.11.2020 Conway Charles
Chief Scientific Officer		 Kjøpe 91.36 274 080 3000 0 0.01 link
25.11.2020 27.11.2020 Coric Vlad
Chief Executive Officer		 Kjøpe 91.36 1 000 390 10950 0 0.02 link
25.11.2020 27.11.2020 Engelhart James
Chief Financial Officer		 Kjøpe 91.36 338 032 3700 0 0.01 link
25.11.2020 27.11.2020 Gentile Kimberly
SVP, Clinical Operations		 Kjøpe 91.36 342 600 3750 0 0.01 link
25.11.2020 27.11.2020 JONES WILLIAM A JR
CCO-Migraine & Common Disease		 Kjøpe 91.36 274 080 3000 0 0.01 link
25.11.2020 27.11.2020 Stock Elyse
Chief Medical Officer		 Kjøpe 91.36 308 340 3375 0 0.01 link
25.11.2020 27.11.2020 Tilton John
Chief Commercial Officer		 Kjøpe 91.36 114 200 1250 0 0 link

Institusjoner Volum Dele, %
Stifel Financial Corporation 6225811 7.63
Janus Henderson Group PLC 5901343 7.23
Blackrock Inc. 5762738 7.06
Suvretta Capital Management, LLC 4572836 5.6
State Street Corporation 3870839 4.74
Price (T.Rowe) Associates Inc 3134323 3.84
RP Management, LLC 2936507 3.6
Point72 Asset Management, L.P. 2483567 3.04
Adage Capital Partners GP L.L.C. 2020644 2.48
FMR, LLC 1928992 2.36

ETF Dele, % Lønnsomhet for året, % Utbytte, %
PSYK ETF 7.04 0
iShares Neuroscience and Healthcare ETF 4.14142 19.72 0.03
iShares Russell 2000 Growth ETF 0.22426 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.13211 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.13211 587.89 0.72598
iShares ESG Aware MSCI USA Small-Cap ETF 0.08795 18.09 1.49366
iShares Morningstar Small-Cap ETF 0.06651 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.06651 391.25 1.60498
iShares Russell 3000 ETF 0.00529 24.83 1.43482



Veileder Stillingstittel Betaling Fødselsår
Ms. Kimberly Gentile Senior Vice President of Clinical Operations 858.65k 1966 (59 år)
Mr. Clifford Bechtold M.S. President, GM of Biohaven Ireland & Chief Compliance Officer N/A
Mr. George C. Clark VP & Chief Accounting Officer N/A 1984 (41 år)
Dr. Vladimir Coric M.D. Chairman & CEO 1.96M 1971 (54 år)
Mr. Matthew Buten Chief Financial Officer 1.05M 1961 (64 år)
Dr. Bruce D. Car DACVP, Ph.D. Chief Scientific Officer 883.03k 1962 (63 år)
Ms. Jennifer Porcelli Vice President of Investor Relations N/A
Mr. John Tilton Chief Commercial Officer of Rare Diseases N/A 1968 (57 år)
Ms. Deb Young Director of Regulatory Affairs & Operations N/A
Mr. Warren Volles J.D. General Counsel & Chief Legal Officer N/A

Adresse: United States, New Haven, CT , 215 Church Street - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.biohavenpharma.com